In the assessment of 12-month price targets, analysts unveil insights for AVITA Medical, presenting an average target of $22.0, a high estimate of $25.00, and a low estimate of $14.00. This current ...

On Friday, Cantor Fitzgerald analysts maintained their Overweight rating and $19.00 price target for Avita Medical Ltd . (NASDAQ:RCEL) stock, despite the shares being down nearly 50% over the past ...

AVITA Medical (NASDAQ:RCEL – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at D. Boral Capital in a ...

D. Boral Capital initiated coverage with a Buy rating and a $25.00 price target, citing strong growth potential driven by its innovative tissue regeneration technology, Recell. Avita Medical has ...

Under the terms of the new Contract Manufacturing Agreement, effective as of March 17, 2025, AVITA Medical is to manufacture PermeaDerm at its state-of-the-art manufacturing facility in Ventura, ...

We expect the standard of care for treatment of burns to change and Avita’s RECELL to gain significant share in this market. There are a number of emerging treatments in burn and wound care set ...

AVITA Medical’s growth strategy revolves around its innovative product offerings and market expansion initiatives. The company’s flagship RECELL system has been the primary driver of revenue ...

and distribute Cohealyx ™, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm ®, a biosynthetic wound matrix. In international markets, the RECELL System is approved to ...

Feb. 26, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ ... In international markets, the RECELL System is approved to promote skin healing in a wide range of applications including burns ...

For partial and full-thickness injuries treated with Spray-On Skin™ Cells prepared with AVITA Medical’s RECELL® devices, PermeaDerm can be applied to further support healing. Additionally ...

AVITA Medical’s growth strategy revolves around its innovative product offerings and market expansion initiatives. The company’s flagship RECELL system has been the primary driver of revenue, with new ...

Feb. 26, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ ... In international markets, the RECELL System is approved to promote skin healing in a wide range of applications including burns and ...